Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 50, Issue 3, 2012, Pages 884-890

  Mitarai, Satoshi ^a   Kato, Seiya ^a   Ogata, Hideo ^b   Aono, Akio ^b   Chikamatsu, Kinuyo ^a   Mizuno, Kazue ^b   Toyota, Emiko ^c   Sejimo, Akiko ^c   Suzuki, Katsuhiro ^d   Yoshida, Shiomi ^d   Saito, Takefumi ^e   Moriya, Ataru ^e   Fujita, Akira ^f   Sato, Shuko ^f   Matsumoto, Tomoshige ^g   Ano, Hiromi ^g   Suetake, Toshinori ⁱ   Kondo, Yuji ⁱ   Kirikae, Teruo ^h   Moria, Toru ^a  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b Japan Anti Tuberculosis Association   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^e The Center of Chest Diseases and Severe Motor Intellectual Disabilities   (Japan)

^f TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^g OSAKA GENERAL MEDICAL CENTER   (Japan)

^h NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

ⁱ Nipro Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; LEVOFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC KIT; EVALUATION RESEARCH; INTERMETHOD COMPARISON; MUTATIONAL ANALYSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NEW LINE PROBE ASSAY KIT; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPECIES IDENTIFICATION; SPUTUM ANALYSIS;

ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, BACTERIAL; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84863171009     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05638-11     Document Type: Article

References (47)

1. Alcaide F, et al. 1997. Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J. Clin. Microbiol. 35:1959-1964. (Pubitemid 27318686)
2. Alvarez-Uria G. 2010. Lung disease caused by nontuberculous mycobacteria. Curr. Opin. Pulm. Med. 16:251-256.
3. Ando H, et al. 2010. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 54:1793-1799.
4. Ando H, et al. 2011. Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis. J. Med. Microbiol. 60:184-188.
5. Ando H, et al. 2010. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan. Clin. Microbiol. Infect. 16:1164-1168.
6. Aono A, Hirano K, Hamasaki S, Abe C. 2002. Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test. Diagn. Microbiol. Infect. Dis. 44:347-352. (Pubitemid 36120712)
7. Aubry A, et al. 2006. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrob. Agents Chemother. 50:104-112. (Pubitemid 43042909)
8. Aziz MA, et al. 2006. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-Tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 368:2142-2154. (Pubitemid 44914009)
9. Bodmer T, Gurtner A, Scholkmann M, Matter L. 1997. Evaluation of the COBAS AMPLICOR MTB system. J. Clin. Microbiol. 35:1604-1605. (Pubitemid 27216845)
10. Chikamatsu K, et al. 2011. Evaluation of GenoTypeR MTBDRplus for the detection of multi-drug resistant Mycobacterium tuberculosis strains. Kekkaku 86:697-702.
11. Cockerill FR, III, et al. 1995. Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. J. Infect. Dis. 171:240-245.
12. Cooksey RC, Morlock GP, Glickman S, Crawford JT. 1997. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J. Clin. Microbiol. 35:1281-1283. (Pubitemid 27175271)
13. Drouillon V, et al. 2009. Multicenter evaluation of a transcription-reverse transcription concerted assay for rapid detection of Mycobacterium tuberculosis complex in clinical specimens. J. Clin. Microbiol. 47:3461-3465.
14. Duong DA, et al. 2009. Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob. Agents Chemother. 53:4835-4839.
15. Giannoni F, et al. 2005. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:2928-2933. (Pubitemid 40917612)
16. Glassroth J. 2008. Pulmonary disease due to nontuberculous mycobacteria. Chest 133:243-251.
17. Gonzalez R, Hanna BA. 1987. Evaluation of Gen-Probe DNA hybridization systems for the identification of Mycobacterium tuberculosis and Mycobacterium avium-intracellulare. Diagn. Microbiol. Infect. Dis. 8:69-77. (Pubitemid 18030385)
18. Goto M, Oka S, Okuzumi K, Kimura S, Shimada K. 1991. Evaluation of acridinium-ester-labeledDNAprobes for identification of Mycobacterium tuberculosis and Mycobacterium avium-Mycobacterium intracellulare complex in culture. J. Clin. Microbiol. 29:2473-2476.
19. Harmsen D, et al. 2003. RIDOM: comprehensive and public sequence database for identification of Mycobacterium species. BMC Infect. Dis. 3:26.
20. Hillemann D, Rusch-Gerdes S, Richter E. 2007. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640. (Pubitemid 47295497)
21. Hirano K, Abe C, Takahashi M. 1999. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J. Clin. Microbiol. 37:2663-2666. (Pubitemid 29337295)
22. Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C. 1997. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuber. Lung Dis. 78:117-122. (Pubitemid 28080549)
23. Huang WL, Chen HY, Kuo YM, Jou R. 2009. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 47:2520-2524.
24. Kantor IN, et al. 1998. Laboratory services in tuberculosis control. III. Culture. World Health Organization, Geneva, Switzerland.
25. Kapur V, et al. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:1095-1098. (Pubitemid 24100101)
26. Katila ML, Katila P, Erkinjuntti-Pekkanen R. 2000. Accelerated detection and identification of mycobacteria with MGIT 960 and COBAS AMPLICOR systems. J. Clin. Microbiol. 38:960-964. (Pubitemid 30140543)
27. Kudoh S, Kudoh T. 1974. A simple technique for culturing tubercle bacilli. Bull. World Health Organ. 51:71-82.
28. Kusunoki S, et al. 1991. Application of colorimetric microdilution plate hybridization for rapid genetic identification of 22 Mycobacterium species. J. Clin. Microbiol. 29:1596-1603.
29. Lacoma A, et al. 2008. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J. Clin. Microbiol. 46:3660-3667.
30. Miotto P, et al. 2006. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J. Clin. Microbiol. 44:2485-2491. (Pubitemid 44092416)
31. Mitarai S, Kurashima A, Tamura A, Nagai H, Shishido H. 2001. Clinical evaluation of Amplicor Mycobacterium detection system for the diagnosis of pulmonary mycobacterial infection using sputum. Tuberculosis (Edinburgh) 81:319-325. (Pubitemid 34087862)
32. Mokrousov I, et al. 2008. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob. Agents Chemother. 52:2937-2939.
33. Morgan M, Kalantri S, Flores L, Pai M. 2005. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 5:62.
34. Morris S, et al. 1995. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis. 171:954-960.
35. Musser JM. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
36. Park H, et al. 2006. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 44:1619-1624. (Pubitemid 43726246)
37. Raynaud C, et al. 1999. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity. Microbiology 145:1359-1367. (Pubitemid 29294921)
38. Rossau R, et al. 1997. Evaluation of the INNO-LiPA Rif.TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother. 41:2093-2098. (Pubitemid 27422196)
39. Santin M. 2004. Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain. Epidemiol. Infect. 132:425-432. (Pubitemid 38714118)
40. Scorpio A, et al. 1997. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:540-543. (Pubitemid 27098400)
41. Sekiguchi J, et al. 2007. Detection of multidrug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45:179-192. (Pubitemid 46106425)
42. Sekiguchi J, et al. 2007. Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis strains. J. Clin. Microbiol. 45:2802-2807. (Pubitemid 47417318)
43. Taillard C, et al. 2003. Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey. J. Clin. Microbiol. 41:1240-1244. (Pubitemid 36307134)
44. Takakura S, et al. 2005. Rapid detection of Mycobacterium tuberculosis in respiratory samples by transcription-reverse transcription concerted reaction with an automated system. J. Clin. Microbiol. 43:5435-5439. (Pubitemid 41612310)
45. Wayne LG. 1974. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109:147-151.
46. Yuen LK, Leslie D, Coloe PJ. 1999. Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia. J. Clin. Microbiol. 37:3844-3850.
47. Zang Y, Telenti A. 2000. Genetics of drug resistance in Mycobacterium tuberculosis, p.235-254. In G. F. Hatfull, W. R. Jabobs (ed), Molecular genetics of mycobacteria. American Society for Microbiology, Washington, DC.